Purchase Order 75N91024P00630
Award Date
9/24/24
Potential Completion Date
9/23/27
Potential Value
$3.1M
Federal Agency
National Cancer Institute
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,078,000.00 firm fixed-price contract awarded by the National Cancer Institute (NCI) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of gene synthesis, peptide synthesis, and quality control analysis services to support the NCI Surgery Branch's clinical research efforts on mutation-reactive T-cells for the treatment of metastatic cancers. The contract has a 12-month base period with two 12-month option periods. There...
Genscript USA Inc. has been awarded a firm fixed price purchase order valued at twelve thousand fifty-four dollars and fifty cents ($12,054.50) by the National Institutes of Health's National Cancer Institute to conduct research in antibody engineering using DNA. The work will be performed in Piscataway, New Jersey through March 31st, 2024. No set-aside designation was applied to this contract for antibody engineering with DNA awarded by the Department of Health and Human Services agency to...
This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $15,289.00 contract will run through September 30, 2024 and does not have a set-aside designation. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services that support...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $3,182.40 firm fixed price delivery order is for gene synthesis services. Genscript specializes in providing customized DNA, antibodies, proteins, peptides, and other molecular biology products and services to support biomedical research and public health initiatives...
This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, was issued by the National Cancer Institute, a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $4,217.03 firm fixed-price delivery order is for peptide services and does not have a set-aside designation. Genscript is a major provider of molecular biology products and services to federal agencies, including the NIH, Centers...
This federal contract award was made by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $7,465.65 firm fixed-price delivery order supports Genscript's provision of peptide and gene synthesis services to the agency. While the contract does not have a set-aside designation, Genscript has received previous small business awards from the National Institutes of...
This federal contract award is to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, for $3,903.76. The contract is a delivery order with a firm fixed price, awarded by the National Cancer Institute, which is a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract is for "Peptide Services" and does not have a set-aside designation. Genscript, a for-profit organization, has received...
This contract was awarded by the National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $5,353.40 firm fixed price delivery order is for peptide services and was completed on September 9, 2015. The contract has no set-aside designation. Genscript is a supplier of various products and services to federal agencies, including gene synthesis, gene editing, custom protein and antibody production, and...
This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for PEPTIDE SERVICES/GENSCRIPT/MARIA PARKHURST. The $3,222.30 firm fixed-price delivery order was awarded on September 4, 2015 by the National Cancer Institute, a component of the Department of Health and Human Services. The contract, which does not have a set-aside designation, supports Genscript's provision of a range of molecular biology products and services, including gene...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $20,092.74 firm fixed price contract is for custom gene synthesis services. The contract has no set-aside designation. Genscript specializes in gene synthesis, gene editing, and other molecular biology services, and has received...